• Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents

    1 month ago - By News Medical

    The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2 among adolescents.
    Read more ...